Tag Archives: cancer

Hormonal treatments for prostate cancer may prevent or limit COVID-19 symptoms

Men have roughly twice the risk of developing severe disease and dying from COVID-19 than women. Scientists say this is in part because women mount stronger immune reactions to the disease’s microbial cause: the infamous coronavirus called SARS-CoV-2. Now research with prostate cancer patients points to another possible explanation, which is that the male sex… Read More »

Chadwick Boseman’s Death Is A Reminder That Colorectal Cancer Rates Are Rising In Younger People

US actor Chadwick Boseman poses in the press room during the 2019 American Music Awards at the … [+] Microsoft theatre on November 24, 2019 in Los Angeles. Boseman recently passed away from colorectal cancer (Photo by Valerie MACON / AFP) AFP via Getty Images The death of actor Chadwick Boseman was announced yesterday evening… Read More »

Merck’s Keytruda sets up Opdivo showdown with esophageal cancer victory

After archrival Opdivo from Bristol-Myers Squibb posted a pair of esophageal cancer wins last week, Merck & Co.’s Keytruda is determined not to be left behind. The New Jersey drugmaker Wednesday said a combination of its PD-1 blockbuster plus chemo had topped chemo at keeping cancer at bay and extending patients’ lives in a trial… Read More »

WCLC: Lilly, Innovent tout Tyvyt front-line lung cancer win. Can it challenge Merck’s Keytruda?

With its latest trial win, Eli Lilly and its Chinese partner Innovent Biologics are eyeing an all-important front-line non-small cell lung cancer approval in China for their PD-1 checkpoint inhibitor, Tyvyt. But competition with Merck & Co.’s formidable Keytruda lies ahead. Adding Tyvyt (sintilimab) to Lilly’s Alimta and platinum chemo significantly extended the time to… Read More »

FDA Approves Trodelvy (sacituzumab govitecan-hziy) for Previously-Treated Metastatic Triple Negative Breast Cancer

FDA Approves Trodelvy (sacituzumab govitecan-hziy) for Previously-Treated Metastatic Triple Negative Breast Cancer Print this page Morris Plains, N.J., April 22, 2020 — Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today announced that the U.S. Food and Drug Administration (FDA) has approved Trodelvy™ (sacituzumab govitecan-hziy) for the treatment… Read More »